31 results
8-K
EX-4.1
STAB
Statera Biopharma, Inc.
15 Nov 22
Entry into a Material Definitive Agreement
6:04am
8-K
EX-4.1
STAB
Statera Biopharma, Inc.
4 Nov 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
STAB
Statera Biopharma, Inc.
24 Oct 22
Statera Biopharma Files Form 10-Q and Reaches Agreement with Silverback Capital and AVOF
6:08am
8-K
EX-4.3
STAB
Statera Biopharma, Inc.
24 Mar 22
Statera Biopharma Announces Pricing of $5.7 Million Underwritten Public Offering
5:44pm
8-K
EX-4.1
STAB
Statera Biopharma, Inc.
24 Mar 22
Statera Biopharma Announces Pricing of $5.7 Million Underwritten Public Offering
5:44pm
8-K
EX-4.2
dqx 18n2re23
24 Mar 22
Statera Biopharma Announces Pricing of $5.7 Million Underwritten Public Offering
5:44pm
8-K
EX-4.1
s39kob47elethy6g8dn
7 Feb 22
Statera Biopharma Announces Pricing of $2.0 Million Registered Direct Offering
2:59pm
8-K
EX-4.1
ff7xxkhd
23 Feb 21
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock
5:30pm
8-K
EX-4.2
hwz8z5d e8be
3 Jun 20
Cleveland Biolabs Announces $3.175 Million Registered Direct Offering Priced At-the-market Under Nasdaq Rules
4:06pm
8-K
EX-4.1
c3txjgvzpnyq8y
3 Jun 20
Cleveland Biolabs Announces $3.175 Million Registered Direct Offering Priced At-the-market Under Nasdaq Rules
4:06pm
8-K
EX-4.1
ktjh6k
9 Feb 15
Cleveland BioLabs Announces $4.2 Million Financing
12:00am
8-K
EX-4.2
np4mjc7 ux9x7kz28
9 Feb 15
Cleveland BioLabs Announces $4.2 Million Financing
12:00am
8-K
EX-4.1
vq75igx
8 Sep 14
Cleveland BioLabs and Sabby Announce Resolution of Litigation
12:00am
8-K
EX-4.2
tfplcca4 saseuj3o
8 Sep 14
Cleveland BioLabs and Sabby Announce Resolution of Litigation
12:00am
8-K
EX-4.1
hk0vtv6mrxa 3cfa
20 Jun 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-4.1
a3ska9ng
15 Jan 14
Cleveland BioLabs Announces $7 Million At-The-Market Registered Direct Offering
12:00am